ESKAMEL
ESKAMEL, licence 80091966: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Sato Pharmaceutical
- NPN or DIN-HM
- 80091966
- Status
- Active licence
- Licence date
- 29 April 2019
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Soufre Source : Soufre | 8.0 Pour cent | Not calculated |
Non-medicinal ingredients
Parfum, Ethanol, Hydroxyde de potassium, Bentonite, Propylène glycol, Oxyde de fer noir, Eau purifiée, Oxyde de fer jaune, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12.0 Année(s) | Not specified | Not specified |
Uses authorised in Canada
For the treatment/management of acne.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Apply only to areas with acne. For external use only. Keep out of reach of children. If swallowed, call a Poison Control Centre or get medical help right away. Skin irritation and dryness are more likely to occur when using another topical acne product at the same time. If irritation occurs, use only one product at a time. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. For more severe cases, and/or if improvement is not apparent within 6-8 weeks, consult a health care professional. Do not use - on broken skin. - on large areas of the skin.
- Contre-indications
If you develop hives, swelling of eyes and mouth, blistering or difficulty breathing, get medical help right away.
- Effets indésirables connus
If you develop severe irritation, burning or itching of the skin, discontinue use and consult a health care professional.
Source
Official Health Canada record, licence 80091966
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.